Enforcement Report - Week of April 3, 2024
The US Food and Drug Administration (FDA) recently warned three drugmakers for good manufacturing practice (GMP) violations and a California-based diagnostic maker for distributing reagents without submitting premarket notification or obtaining premarket approval for the tests.
Apothecus Pharmaceutical Corp Receives FDA Warning Letter